Tech Company Financing Transactions

Nuclein Funding Round

On 3/27/2021, Nuclein landed $14 million in Series B investment from Trinity Private Equity Group and private investors.

Transaction Overview

Company Name
Announced On
3/27/2021
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series B
Investors

Trinity Private Equity Group (Lead Investor)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
7301 N. Fm 620 Rd. 155-113
Austin, TX 78730
USA
Email Address
Not Recorded
Overview
Nuclein, LLC was founded in 2017 by long-time Austin biotechnology entrepreneurs Alan Blake and Dr. Richard Crockett. The company's vision is to enable simple, affordable, rapid, and accurate disease testing for everyone.
Profile
Nuclein LinkedIn Company Profile
Social Media
Nuclein Company Twitter Account
Company News
Nuclein News
Facebook
Nuclein on Facebook
YouTube
Nuclein on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alan Blake
  Alan Blake LinkedIn Profile  Alan Blake Twitter Account  Alan Blake News  Alan Blake on Facebook
President
Richard Crockett
  Richard Crockett LinkedIn Profile  Richard Crockett Twitter Account  Richard Crockett News  Richard Crockett on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/27/2021: Pilot venture capital transaction
Next: 3/27/2021: Foodsmart venture capital transaction

 

Share this article

 


Where The Data Comes From

We document funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary